by Matthew Manobianco | Feb 23, 2026 | News
New commercial kit brings Nature Communications-validated methylation analysis chemistry to researchers working with low-input and cfDNA samples Cambridge, MA – Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official...
by Matthew Manobianco | Nov 12, 2025 | News
Re-engineered bisulfite chemistry overcomes decades-old limitations in methylation sequencing Cambridge, MA – Traditional bisulfite sequencing damages DNA, while enzyme-based alternatives are inconsistent. A novel methylation analysis method, called UMBS-seq,...
by Matthew Manobianco | Oct 14, 2025 | News
CAMBRIDGE, Mass. — Ellis Bio Inc., a genomics biotechnology company, announced the publication of a new bioRxiv preprint from the laboratory of its scientific founder, Professor Chuan He of The University of Chicago (UChicago)/Howard Hughes Medical Institute (HHMI),...
by Matthew Manobianco | Jul 24, 2025 | News
Explore how Ellis Bio is revolutionizing DNA methylation analysis with their groundbreaking bisulfite conversion kits at ADLM 2025. Ellis Bio is attending ADLM 2025 Chicago, IL – The Association for Diagnostics & Laboratory Medicine (ADLM) in partnership with...
by Matthew Manobianco | May 15, 2025 | Articles
New bisulfite chemistry delivers high-yield recovery and NGS compatibility for challenging epigenomic applications Chicago, IL – Ellis Bio Inc, a biotechnology company accelerating innovation in epigenomics, today announced the launch of its SuperMethyl™ Max Kit, the...
